Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate.
Limani P, Linecker M, Kachaylo E, Tschuor C, Kron P, Schlegel A, Ungethuem U, Jang JH, Georgiopoulou S, Nicolau C, Lehn JM, Graf R, Humar B, Clavien PA. Limani P, et al. Among authors: nicolau c. Clin Cancer Res. 2016 Dec 1;22(23):5887-5897. doi: 10.1158/1078-0432.CCR-15-3112. Epub 2016 Aug 3. Clin Cancer Res. 2016. PMID: 27489288 Free article.
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.
Limani P, Linecker M, Kron P, Samaras P, Pestalozzi B, Stupp R, Jetter A, Dutkowski P, Müllhaupt B, Schlegel A, Nicolau C, Lehn JM, Petrowsky H, Humar B, Graf R, Clavien PA. Limani P, et al. Among authors: nicolau c. BMC Cancer. 2016 Oct 19;16(1):812. doi: 10.1186/s12885-016-2855-3. BMC Cancer. 2016. PMID: 27756258 Free PMC article. Clinical Trial.
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors.
Schneider MA, Linecker M, Fritsch R, Muehlematter UJ, Stocker D, Pestalozzi B, Samaras P, Jetter A, Kron P, Petrowsky H, Nicolau C, Lehn JM, Humar B, Graf R, Clavien PA, Limani P. Schneider MA, et al. Among authors: nicolau c. Nat Commun. 2021 Jun 21;12(1):3807. doi: 10.1038/s41467-021-24069-w. Nat Commun. 2021. PMID: 34155211 Free PMC article. Clinical Trial.
Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.
Biolo A, Greferath R, Siwik DA, Qin F, Valsky E, Fylaktakidou KC, Pothukanuri S, Duarte CD, Schwarz RP, Lehn JM, Nicolau C, Colucci WS. Biolo A, et al. Among authors: nicolau c. Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1926-9. doi: 10.1073/pnas.0812381106. Epub 2009 Feb 9. Proc Natl Acad Sci U S A. 2009. PMID: 19204295 Free PMC article.
346 results